Compounds > xamoterol
Page last updated: 2024-09-04

xamoterol and Pulmonary Disease, Chronic Obstructive

xamoterol has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ormiston, T; Salpeter, E; Salpeter, S2

Reviews

2 review(s) available for xamoterol and Pulmonary Disease, Chronic Obstructive

ArticleYear
Cardioselective beta-blocker use in patients with reversible airway disease.
    The Cochrane database of systematic reviews, 2001, Issue:2

    Topics: Acebutolol; Adrenergic beta-Antagonists; Asthma; Celiprolol; Female; Forced Expiratory Volume; Humans; Male; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Xamoterol

2001
Cardioselective beta-blockers for reversible airway disease.
    The Cochrane database of systematic reviews, 2002, Issue:1

    Topics: Acebutolol; Adrenergic beta-Antagonists; Asthma; Celiprolol; Female; Forced Expiratory Volume; Humans; Male; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Xamoterol

2002